Americas Will Continue to Dominate the Global DNA Sequencing Products Market Until 2020, Says Technavio

LONDON--()--The global DNA sequencing products market is expected to grow at a CAGR of close to 19% during the forecast period, according to Technavio’s latest report.

In this report, Technavio covers the market outlook and growth prospects of the global DNA sequencing products market for 2016-2020. To calculate the market size, the report considers revenue generated from the sale of equipment, reagents, and consumables used in DNA sequencing.

“Advances in the applications of genome sequencing in molecular biology and biomedical research have helped scientists study some of most complex biological processes such as human brain function and disease predisposition. With reduction in the cost of genome sequencing, many medical facilities and research laboratories will start adopting DNA sequencing systems. This will consequently lead to the rapid growth of the global DNA sequencing products market in the coming years,” says Barath Palada, a lead analyst at Technavio for research on life science research tools.

Technavio’s research study segments the global DNA sequencing products market into the following regions:

  • Americas
  • EMEA
  • APAC

Americas: largest market for DNA sequencing products

The DNA sequencing products market in the Americas is dynamic, with the presence of more than 20 established companies that compete for the sales of these products. “Many vendors are receiving CLIA certification for developing DNA sequencing products, some of which include Illumina, GE Healthcare, Expression Analysis, and Ambry Genetics. This will lead many vendors to develop advanced products and entering the market during the forecast period,” says Barath.

The global DNA sequencing products market presents significant opportunities for vendors, particularly in the US, as clinical laboratories and pharmaceutical companies are extensively adopting DNA sequencing technologies. The incidence of chronic diseases such as Alzheimer's disease, multiple sclerosis, autoimmune diseases, and cancer is on the rise in the region. For instance, in 2014, the Alzheimer's Association in the US estimated that 4.69 million people aged 65 and above have Alzheimer's disease, which increased to 5.2 million in 2015. DNA sequencing products help in analyzing the affected genes, leading to faster drug discovery and improved development of personalized medicine.

Ask for a sample of this report: http://goo.gl/qztmjf

DNA sequencing products market in EMEA

The market in EMEA will grow at a rapid pace during the forecast period. Germany, France, and Italy in Western Europe dominated the market in this region in 2015. In these countries, vendors are developing non-invasive prenatal testing and comprehensive oncology panels that require DNA sequencing products for accurate results.

However, reimbursement policies governing DNA sequencing products are uncertain, as public and private players in this region are undecided as to when to provide insurance coverage. The fundamental right of European citizens to access cross-border healthcare treatment makes the reimbursement scenario difficult for the market players. This has led to a geographical disparity in the availability of DNA sequencing test, which is further preventing medical facilities from implementing associated technologies. In countries such as Kenya and South Africa, only a few laboratories conduct DNA sequencing research due to limited government funding. This has led to decreased implementation of DNA sequencing products in MEA.

DNA sequencing products market in APAC

The DNA sequencing products market in APAC was valued at USD 428.8 million in 2015 and will reach USD 1.01 billion by 2020, growing at a CAGR of 18.92%.

The market in APAC will grow at a rapid pace during the forecast period. In countries such as Japan, China, and India, the use of DNA sequencing products is increasing. This is because the governments and private companies are establishing new research laboratories for new drug discoveries in medical areas such as oncology. For instance, the Beijing Genomics Institute in China has the world's highest sequencing capacity, with more than 150 units of DNA sequencers.

Some of the top vendors in the global DNA sequencing products market highlighted in the report are:

  • Illumina
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Pacific Biosciences

Browse Related Reports:

Purchase these three reports for the price of one by becoming a Technavio subscriber. Subscribing to Technavio’s reports allows you to download any three reports per month for the price of one. Contact enquiry@technavio.com with your requirements and a link to our subscription platform.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

The global DNA sequencing products market is expected to grow at a CAGR of close to 19% during the forecast period, according to Technavio’s latest report.

$Cashtags

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com